An insider’s view of generic-drug pricing

Source: David Lazarus, Los Angeles Times (Free Registration)

Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers.

When it comes to patented name-brand drugs, he told me, pharmaceutical companies try to get away with the highest prices possible.

Read Full Article: An insider’s view of generic-drug pricing

 

Tags/Keywords


 

Quick Menu

Support Consumer Action

Support Consumer
Facebook FTwitter T

Consumer Help Desk

Advocacy